Search results for “Hormone-Resistant Prostate Cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 41 patents, we discovered top 14 key players by total patent application. Koninklijke Philips NV, Chameleon Pharma Consulting, Philips are dominant in this area. They take 68.29% of the total patent filing.
Koninklijke Philips NV
Noord-Holland, Netherlands
Patent: 14
Chameleon Pharma Consulting
Berlin, Germany
Patent: 9
Philips
Saudi Arabia
Patent: 5
Ambrilia Biopharma, Inc.
Canada
Patent: 3
Pfizer Inc.
New York, United States
Patent: 1
Hybrigenics SA
France
Patent: 1
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 1
Procyon Biopharma, Inc.
Canada
Patent: 1
CureVac SE
Baden-Württemberg, Germany
Patent: 1
Aragon Pharmaceuticals, Inc.
California, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 31 patents, we discovered top 3 universities and scientific research institutions by total patent application.
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 4
The Johns Hopkins University
United States
Patent: 1
Zhengzhou University
Henan Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: